Clinical picture of EPM1-Unverricht-Lundborg disease
- PMID: 18325013
- DOI: 10.1111/j.1528-1167.2008.01546.x
Clinical picture of EPM1-Unverricht-Lundborg disease
Abstract
Unverricht-Lundborg disease (ULD), progressive myoclonic epilepsy type 1 (EPM1, OMIM254800), is an autosomal recessively inherited neurodegenerative disorder characterized by age of onset from 6 to 16 years, stimulus-sensitive myoclonus, and tonic-clonic epileptic seizures. Some years after the onset ataxia, incoordination, intentional tremor, and dysarthria develop. Individuals with EPM1 are mentally alert but show emotional lability, depression, and mild decline in intellectual performance over time. The diagnosis of EPM1 can be confirmed by identifying disease-causing mutations in a cysteine protease inhibitor cystatin B (CSTB) gene. Symptomatic pharmacologic and rehabilitative management, including psychosocial support, are the mainstay of EPM1 patients' care. Valproic acid, the first drug of choice, diminishes myoclonus and the frequency of generalized seizures. Clonazepam and high-dose piracetam are used to treat myoclonus, whereas levetiracetam seems to be effective for both myoclonus and generalized seizures. There are a number of agents that aggravate clinical course of EPM1 such as phenytoin aggravating the associated neurologic symptoms or even accelerating cerebellar degeneration. Sodium channel blockers (carbamazepine, oxcarbazepine) and GABAergic drugs (tiagabine, vigabatrin) as well as gabapentin and pregabalin may aggravate myoclonus and myoclonic seizures. EPM1 patients need lifelong clinical follow-up, including evaluation of the drug-treatment and comprehensive rehabilitation.
Similar articles
-
Progressive Myoclonic Epilepsy Type 1.2004 Jun 24 [updated 2020 Jul 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2004 Jun 24 [updated 2020 Jul 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301321 Free Books & Documents. Review.
-
Molecular background of EPM1-Unverricht-Lundborg disease.Epilepsia. 2008 Apr;49(4):557-63. doi: 10.1111/j.1528-1167.2007.01422.x. Epub 2007 Nov 19. Epilepsia. 2008. PMID: 18028412 Review.
-
Unverricht-Lundborg progressive myoclonus epilepsy in Oman.Pediatr Neurol. 2008 Apr;38(4):252-5. doi: 10.1016/j.pediatrneurol.2007.11.006. Pediatr Neurol. 2008. PMID: 18358403
-
Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.Epilepsia. 2006 Oct;47(10):1650-4. doi: 10.1111/j.1528-1167.2006.00638.x. Epilepsia. 2006. PMID: 17054687
-
Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.Eur J Hum Genet. 2007 Feb;15(2):185-93. doi: 10.1038/sj.ejhg.5201723. Epub 2006 Sep 27. Eur J Hum Genet. 2007. PMID: 17003839
Cited by
-
Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.PLoS One. 2016 Jun 29;11(6):e0158195. doi: 10.1371/journal.pone.0158195. eCollection 2016. PLoS One. 2016. PMID: 27355630 Free PMC article.
-
Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.Cells. 2022 Nov 4;11(21):3491. doi: 10.3390/cells11213491. Cells. 2022. PMID: 36359887 Free PMC article.
-
The network sustaining action myoclonus: a MEG-EMG study in patients with EPM1.BMC Neurol. 2016 Nov 7;16(1):214. doi: 10.1186/s12883-016-0738-5. BMC Neurol. 2016. PMID: 27821136 Free PMC article.
-
Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression.Orphanet J Rare Dis. 2013 Oct 28;8:173. doi: 10.1186/1750-1172-8-173. Orphanet J Rare Dis. 2013. PMID: 24164873 Free PMC article.
-
Brain inflammation is accompanied by peripheral inflammation in Cstb -/- mice, a model for progressive myoclonus epilepsy.J Neuroinflammation. 2016 Nov 28;13(1):298. doi: 10.1186/s12974-016-0764-7. J Neuroinflammation. 2016. PMID: 27894304 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
